1Post-Graduate Trainee, Department of Public Health Dentistry, Institute of Dental Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India
2Professor, Department of Public Health Dentistry, Institute of Dental Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India
3Professor & Head, Department of Public Health Dentistry, Institute of Dental Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India
4Senior Lecturer, Department of Public Health Dentistry, Institute of Dental Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India
*Corresponding Author: Dr. Dharmashree Satyarup Professor, Department of Public Health Dentisty, Institute of Dental Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India, e-mail: dharmashree_s@yahoo.com
Online published on 27 March, 2020.
In the current scenario, even if there is much advances in treatment modalities, the survival of patients with cancer has not improved significantly owning to late detection and failures. The purpose of this article is to explore the role of blood biomarkers such as Antioxidants, Trace elements, proteins, antibodies etc to detect oral squamous cell carcinoma (OSCC) and premalignant lesions (PML). Key biological molecules or markers that can be linked to cancer development, risk assessment, screening, repetition probability, indicating prognosis, indicating invasion and monitoring therapeutic responses of cancer which are identified with Molecular biology and oncology research studies on oral cancer biomarkers.
Blood Biomarkers, oral cancer, oral squamous cell carcinoma, premalignant lesions
